Edit Entry | Edit CV

Douglas J. Robertson, MD, MPH

Title(s)
Professor of Medicine
Professor of The Dartmouth Institute

Department(s)
Medicine
The Dartmouth Institute

Education
Georgetown University, BS 1988
U. Connecticut School of Medicine, MD 1992
University of North Carolina, MPH 2000

Programs
The Dartmouth Institute for Health Policy and Clinical Practice

Websites
http://vaoutcomes.org/robertson.php

Academic Analytics
View Profile

Contact Information

VA Medical Center
215 N Main St
Mail Code 111E
White River Junction VT 05009

Office: 802 295 9363
Phone: x5590


Professional Interests

Colorectal Cancer Epidemiology and Outcomes
Pharmacoepidemiology of GI disease

Grant Information

1.Prospective Evaluation of Risk Factors for Large (≥ 1cm) Colonic Adenomas in Asymptomatic Subjects. A large multicenter trial funded by the VA Cooperative Studies Program. Principal Investigator: David Lieberman. (Role: Site PI)
2.Translation of Colorectal Cancer Screening Guidelines to Practice-A System Intervention. A multicenter trial funded by the VA Colorectal Cancer Queri. Principal Investigator: Linda Humphrey. (Role Site PI)
3.Colorectal Chemoprevention with Calcium and Vitamin D. A large randomized placebo controlled trial funded by the National Institutes of Health. Principal Investigator: John Baron (Role Clinical Director)
4.Developing Sensible Screening Strategies Following Colonoscopy. VA Health Services Research & Development Career Development Award (Principal Investigator)

Courses Taught

Scientific Basis of Medicine-GI Section


Selected Publications

 

Colonoscopy vs. the Fecal Immunochemical Test: Which is Best?
Robertson DJ, Rex DK, Ciani O, Drummond MF
Gastroenterology. 2024 Feb 9; pii: S0016-5085(24)00164-1. doi: 10.1053/j.gastro.2023.12.027. Epub 2024 Feb 9.
PMID: 38342196

Fecal Immunochemical Test Screening: Maximizing Success by Minimizing Failure.
Anderson JC, Robertson DJ
Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):183-185. doi: 10.1158/1055-9965.EPI-23-1393.
PMID: 38317627

Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
Robertson DJ, Dominitz JA, Beed A, Boardman KD, Del Curto BJ, Guarino PD, Imperiale TF, LaCasse A, Larson MF, Gupta S, Lieberman D, Planeta B, Shaukat A, Sultan S, Menees SB, Saini SD, Schoenfeld P, Goebel S, von Rosenvinge EC, Baffy G, Halasz I, Pedrosa MC, Kahng LS, Cassim R, Greer KB, Kinnard MF, Bhatt DB, Dunbar KB, Harford WV Jr, Mengshol JA, Olson JE, Patel SG, Antaki F, Fisher DA, Sullivan BA, Lenza C, Prajapati DN, Wong H, Beyth R, Lieb JG 2nd, Manlolo J, Ona FV, Cole RA, Khalaf N, Kahi CJ, Kohli DR, Rai T, Sharma P, Anastasiou J, Hagedorn C, Fernando RS, Jackson CS, Jamal MM, Lee RH, Merchant F, May FP, Pisegna JR, Omer E, Parajuli D, Said A, Nguyen TD, Tombazzi CR, Feldman PA, Jacob L, Koppelman RN, Lehenbauer KP, Desai DS, Madhoun MF, Tierney WM, Ho MQ, Hockman HJ, Lopez C, Carter Paulson E, Tobi M, Pinillos HL, Young M, Ho NC, Mascarenhas R, Promrat K, Mutha PR, Pandak WM Jr, Shah T, Schubert M, Pancotto FS, Gawron AJ, Underwood AE, Ho SB, Magno-Pagatzaurtundua P, Toro DH, Beymer CH, Kaz AM, Elwing J, Gill JA, Goldsmith SF, Yao MD, Protiva P, Pohl H, Kyriakides T, CONFIRM Study Group
JAMA Netw Open. 2023 Jul 3;6(7):e2321730. doi: 10.1001/jamanetworkopen.2023.21730. Epub 2023 Jul 3.
PMID: 37432690

Understanding the Results of a Randomized Trial of Screening Colonoscopy.
Dominitz JA, Robertson DJ
N Engl J Med. 2022 Oct 27;387(17):1609-1611. doi: 10.1056/NEJMe2211595. Epub 2022 Oct 9.
PMID: 36214591

Response to Yoo and Sonnenberg & Braillon.
Patel SG, May FP, Anderson JC, Burke CA, Dominitz JA, Gross SA, Jacobson BC, Shaukat A, Robertson DJ
Am J Gastroenterol. 2022 Jul 1;117(7):1170-1171. doi: 10.14309/ajg.0000000000001829.
PMID: 35765910

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer.
Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ
Gastroenterology. 2022 Jun;162(7):2063-2085. doi: 10.1053/j.gastro.2022.02.021. Epub 2022 Apr 26.
PMID: 35487791

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer.
Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ
Gastrointest Endosc. 2022 Jun;95(6):1025-1047. doi: 10.1016/j.gie.2022.02.044. Epub 2022 Apr 26.
PMID: 35487765

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer.
Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ
Am J Gastroenterol. 2022 Jun 1;117(6):846-864. doi: 10.14309/ajg.0000000000001755. Epub 2022 Apr 26.
PMID: 35471415

Stopping Surveillance in Gastrointestinal Conditions: Thoughts on the Scope of the Problem and Potential Solutions.
Calderwood AH, Robertson DJ
Gastroenterology. 2022 Aug;163(2):345-349. doi: 10.1053/j.gastro.2022.04.009. Epub 2022 Apr 12.
PMID: 35427573

Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer.
Patel SG, May FP, Anderson JC, Burke CA, Dominitz JA, Gross SA, Jacobson BC, Shaukat A, Robertson DJ
Am J Gastroenterol. 2022 Jan 1;117(1):57-69. doi: 10.14309/ajg.0000000000001548.
PMID: 34962727

View more publications on PubMed